Together, the concurrent elevation of NOTCH4 and JAG2 supports sustained Notch signaling across diverse tumor subtypes, which in the case of JAG2 may be additionally related to the lack of inhibitory action by miRNAs. Here, JAG2 is linked to neoplasm.